Intrauterine device
92 results
1 - 92
Progestin intrauterine devices versus copper intrauterine devices for emergency contraception- Misoprostol for intrauterine device placement
- Analgesics for intrauterine device placement
- Local anesthetics for intrauterine device placement
- Interventions for pain with intrauterine device insertion
- Antibiotic prophylaxis for intrauterine contraceptive device insertion
- Frameless versus classical intrauterine device for contraception: Cochrane systematic review
- Immediate postabortal insertion of intrauterine devices: Cochrane systematic review
- Immediate postpartum insertion of intrauterine device for contraception: Cochrane systematic review
- Levonorgestrel‐releasing intrauterine device (LNG‐IUD) for symptomatic endometriosis following surgery
- Strategies for improving the acceptability and acceptance of the copper intrauterine device: Cochrane systematic review
- Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use
- Progestogen‐releasing intrauterine systems versus other forms of reversible contraceptives for contraception
- Levonorgestrel‐releasing intrauterine system for endometrial hyperplasia
- Hormonal and intrauterine methods for contraception for women aged 25 years and younger
- Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke
- Surgery versus medical therapy for heavy menstrual bleeding
- Progestogen‐releasing intrauterine systems for heavy menstrual bleeding
- Internal versus external tocodynamometry during induced or augmented labour
- Copper containing intra‐uterine devices versus depot progestogens for contraception
- Anti‐adhesion therapy following operative hysteroscopy for treatment of female subfertility
- Immediate versus delayed postpartum insertion of contraceptive implant and IUD for contraception
- Progestogens or progestogen‐releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy)
- Cyclical progestogens for heavy menstrual bleeding
- Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen
- Copper containing, framed intra‐uterine devices for contraception
- Hormonal contraception for women exposed to HIV infection: Cochrane systematic review
- Hormonal contraception for women at risk of HIV infection
- Hormonal versus non‐hormonal contraceptives in women with diabetes mellitus type 1 and 2
- Endometrial injury for pregnancy following sexual intercourse or intrauterine insemination
- Non‐surgical interventions for treating heavy menstrual bleeding (menorrhagia) in women with bleeding disorders
- Combination injectable contraceptives for contraception
- Combined oral contraceptives: venous thrombosis: Cochrane systematic review
- Metformin for endometrial hyperplasia
- Interventions for emergency contraception
- Spinal manipulation for dysmenorrhoea
- Antifibrinolytics for heavy menstrual bleeding
- Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus
- Transcutaneous electrical nerve stimulation for primary dysmenorrhoea: Cochrane systematic review
- Steroidal contraceptives and bone fractures in women: evidence from observational studies
- Combined hormonal versus nonhormonal versus progestin‐only contraception in lactation
- Selective oestrogen receptor modulators (SERMs) for endometriosis
- Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities
- Fertility‐sparing treatment for atypical endometrial hyperplasia and endometrial cancer
- Mechanical and surgical interventions for treating primary postpartum haemorrhage
- Behavioral interventions for improving dual-method contraceptive use: Cochrane systematic review
- Strategies for communicating contraceptive effectiveness
- Interventions for enhancing medication adherence
- Strategies for improving postpartum contraceptive use: evidence from non-randomized studies: Cochrane systematic review
- Dietary supplements for dysmenorrhoea
- Pre‐operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding